InsidersTradesSigma
Follow the Acasti Pharma Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 27 September 2023 (Acquisition). Among the most active insiders: Kavuru Vimal. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Acasti Pharma Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular diseases. It is listed on NASDAQ under the ticker ACST.